Browsing byAuthorLaw, AMK

Jump to a point in the index:
Showing results 1 to 19 of 19
Issue DateTitleAuthor(s)
2022-08-06Temporal profiling of the breast tumour microenvironment reveals collagen XII as a driver of metastasis.Papanicolaou, M; Parker, AL; Yam, M; Filipe, EC; Wu, SZ; Chitty, JL; Wyllie, K; Tran, E; Mok, E; Nadalini, A; Skhinas, JN; Lucas, MC; Herrmann, D; Nobis, M; Pereira, BA; Law, AMK; Castillo, L; Murphy, KJ; Zaratzian, A; Hastings, JF; Croucher, DR; Lim, E; Oliver, BG; Mora, FV; Parker, BL; Gallego-Ortega, D; Swarbrick, A; O'Toole, S; Timpson, P; Cox, TR
2022-07ALTEN: A High-Fidelity Primary Tissue-Engineering Platform to Assess Cellular Responses Ex Vivo.Law, AMK; Chen, J; Colino-Sanguino, Y; Fuente, LRDL; Fang, G; Grimes, SM; Lu, H; Huang, RJ; Boyle, ST; Venhuizen, J; Castillo, L; Tavakoli, J; Skhinas, JN; Millar, EKA; Beretov, J; Rossello, FJ; Tipper, JL; Ormandy, CJ; Samuel, MS; Cox, TR; Martelotto, L; Jin, D; Valdes-Mora, F; Ji, HP; Gallego-Ortega, D
2022-05-03Activation of the viral sensor oligoadenylate synthetase 2 (Oas2) prevents pregnancy-driven mammary cancer metastases.Ho, W-HJ; Law, AMK; Masle-Farquhar, E; Castillo, LE; Mawson, A; O'Bryan, MK; Goodnow, CC; Gallego-Ortega, D; Oakes, SR; Ormandy, CJ
2021-12-17Tumor dissociation of highly viable cell suspensions for single-cell omic analyses in mouse models of breast cancer.Rodriguez de la Fuente, L; Law, AMK; Gallego-Ortega, D; Valdes-Mora, F
2021-11Mammary Tumor Organoid Culture in Non-Adhesive Alginate for Luminal Mechanics and High-Throughput Drug Screening.Fang, G; Lu, H; Rodriguez de la Fuente, L; Law, AMK; Lin, G; Jin, D; Gallego-Ortega, D
2021-08-01Generation and analysis of 3D cell culture models for drug discovery.Belfiore, L; Aghaei, B; Law, AMK; Dobrowolski, JC; Raftery, LJ; Tjandra, AD; Yee, C; Piloni, A; Volkerling, A; Ferris, CJ; Engel, M
2021-04-13Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype.Valdés-Mora, F; Salomon, R; Gloss, BS; Law, AMK; Venhuizen, J; Castillo, L; Murphy, KJ; Magenau, A; Papanicolaou, M; Rodriguez de la Fuente, L; Roden, DL; Colino-Sanguino, Y; Kikhtyak, Z; Farbehi, N; Conway, JRW; Sikta, N; Oakes, SR; Cox, TR; O'Donoghue, SI; Timpson, P; Ormandy, CJ; Gallego-Ortega, D
2021Advancements in 3D Cell Culture Systems for Personalizing Anti-Cancer Therapies.Law, AMK; Rodriguez de la Fuente, L; Grundy, TJ; Fang, G; Valdes-Mora, F; Gallego-Ortega, D
2020-02-27Myeloid-Derived Suppressor Cells as a Therapeutic Target for Cancer.Law, AMK; Valdes-Mora, F; Gallego-Ortega, D
2020-02MCL-1 antagonism enhances the anti-invasive effects of dasatinib in pancreatic adenocarcinoma.Castillo, L; Young, AIJ; Mawson, A; Schafranek, P; Steinmann, AM; Nessem, D; Parkin, A; Johns, A; Chou, A; Law, AMK; Lucas, MC; Murphy, KJ; Deng, N; Gallego-Ortega, D; Caldon, CE; Australian Pancreatic Cancer Genome Initiative (APGI); Timpson, P; Pajic, M; Ormandy, CJ; Oakes, SR
2018-08MASTL overexpression promotes chromosome instability and metastasis in breast cancer.Rogers, S; McCloy, RA; Parker, BL; Gallego-Ortega, D; Law, AMK; Chin, VT; Conway, JRW; Fey, D; Millar, EKA; O'Toole, S; Deng, N; Swarbrick, A; Chastain, PD; Cesare, AJ; Timpson, P; Caldon, CE; Croucher, DR; James, DE; Watkins, DN; Burgess, A
2018-01-01Static droplet array for culturing single live adherent cells in an isolated chemical microenvironmentHassanzadeh-Barforoushi, A; Law, AMK; Hejri, A; Asadnia, M; Ormandy, CJ; Gallego-Ortega, D; Ebrahimi Warkiani, M
2018Single-Cell Transcriptomics in Cancer Immunobiology: The Future of Precision Oncology.Valdes-Mora, F; Handler, K; Law, AMK; Salomon, R; Oakes, SR; Ormandy, CJ; Gallego-Ortega, D
2017-11-16Andy's Algorithms: new automated digital image analysis pipelines for FIJI.Law, AMK; Yin, JXM; Castillo, L; Young, AIJ; Piggin, C; Rogers, S; Caldon, CE; Burgess, A; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR
2017-11A mutation in the viral sensor 2'-5'-oligoadenylate synthetase 2 causes failure of lactation.Oakes, SR; Gallego-Ortega, D; Stanford, PM; Junankar, S; Au, WWY; Kikhtyak, Z; von Korff, A; Sergio, CM; Law, AMK; Castillo, LE; Allerdice, SL; Young, AIJ; Piggin, C; Whittle, B; Bertram, E; Naylor, MJ; Roden, DL; Donovan, J; Korennykh, A; Goodnow, CC; O'Bryan, MK; Ormandy, CJ
2017-07The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Law, AMK; Lim, E; Ormandy, CJ; Gallego-Ortega, D
2017-04The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.Law, AMK; Lim, E; Ormandy, CJ; Gallego-Ortega, D
2016-12-08MCL-1 inhibition provides a new way to suppress breast cancer metastasis and increase sensitivity to dasatinib.Young, AIJ; Law, AMK; Castillo, L; Chong, S; Cullen, HD; Koehler, M; Herzog, S; Brummer, T; Lee, EF; Fairlie, WD; Lucas, MC; Herrmann, D; Allam, A; Timpson, P; Watkins, DN; Millar, EKA; O'Toole, SA; Gallego-Ortega, D; Ormandy, CJ; Oakes, SR
2015-12ELF5 Drives Lung Metastasis in Luminal Breast Cancer through Recruitment of Gr1+ CD11b+ Myeloid-Derived Suppressor Cells.Gallego-Ortega, D; Ledger, A; Roden, DL; Law, AMK; Magenau, A; Kikhtyak, Z; Cho, C; Allerdice, SL; Lee, HJ; Valdes-Mora, F; Herrmann, D; Salomon, R; Young, AIJ; Lee, BY; Sergio, CM; Kaplan, W; Piggin, C; Conway, JRW; Rabinovich, B; Millar, EKA; Oakes, SR; Chtanova, T; Swarbrick, A; Naylor, MJ; O'Toole, S; Green, AR; Timpson, P; Gee, JMW; Ellis, IO; Clark, SJ; Ormandy, CJ